Jean Jethro Alexandre may have done a tremendous service for taxpayers and low-income Americans without health insurance.
CMS proposes deeper 340B drug payment cuts for hospitals, reshaping outpatient cancer economics, consolidation incentives, and patient cost-sharing. The Centers for Medicare & Medicaid Services (CMS) ...
An autoimmune disease diagnosis can mark the start of a difficult medical battle. But for too many patients, it also marks the beginning of a financial one. Many of the 50 million Americans living ...
CMS proposes paying 340B-acquired drugs at ASP minus 33.4% starting CY 2027, replacing ASP plus 6%, based on survey findings that acquisition costs are well below ASP. Projected 2027 impact includes ...
CMS plans to cut what Medicare pays hospitals for drugs bought through the 340B program and push site-neutral payment into a new category of outpatient services, two proposals that together would pull ...